1. FDA grants Bristol-Myers priority review for ide-cel — Is Illumina making an $8B blunder? — Medicare may not cover the cost of the coronavirus vaccine — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Novartis layoffs in development, brace for INDIA

Discussion in 'Industry Rumors' started by anonymous, Mar 11, 2017 at 9:16 AM.

  1. anonymous

    anonymous Guest

    Our great leaders want to try solution that already failed for other companies, they are soooo smart !

    Positions currently opened in India:

    10-20 financial analysts
    20-40 clinical data managers
    20-40 statistical programmers
    10 biostatisticians

    Clinical managers are probably the nexts...

    I do not even understand how FDA and EMEA allow these incompetent folks abroad to be part of the pharma and biotech R&D: #ICH

    Be prepared for your ridiculous severance,
    TRUMP save us !
    Vasella come back !!!